US 10881666
Combination pharmaceutical agents as RSV inhibitors
granted A61KA61K31/4439A61K31/519
Quick answer
US patent 10881666 (Combination pharmaceutical agents as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4439, A61K31/519, A61K31/55, A61K31/5513